Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · IEX Real-Time Price · USD
2.570
-0.020 (-0.77%)
May 31, 2024, 4:00 PM EDT - Market closed
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $181.02 million as of May 31, 2024. Its market cap has increased by 22.97% in one year.
Market Cap
181.02M
Enterprise Value
109.47M
1-Year Change
22.97%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $140.20M to $181.02M, an increase of 29.11%. That is a compound annual growth rate of 5.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 31, 2024 | 181.00M | -0.77% |
May 30, 2024 | 182.40M | 1.96% |
May 29, 2024 | 178.90M | -0.78% |
May 28, 2024 | 180.30M | 2.39% |
May 24, 2024 | 176.10M | -1.57% |
May 23, 2024 | 178.90M | -4.18% |
May 22, 2024 | 186.70M | -2.91% |
May 21, 2024 | 192.30M | -3.51% |
May 20, 2024 | 199.30M | 2.15% |
May 17, 2024 | 195.10M | -2.45% |
May 16, 2024 | 200.00M | 2.67% |
May 15, 2024 | 194.80M | -5.30% |
May 14, 2024 | 205.70M | 6.97% |
May 13, 2024 | 192.30M | - |
May 10, 2024 | 192.30M | -6.51% |
May 9, 2024 | 205.70M | 10.65% |
May 8, 2024 | 185.90M | -9.01% |
May 7, 2024 | 204.30M | 0.79% |
May 6, 2024 | 202.70M | -2.69% |
May 3, 2024 | 208.30M | 0.34% |
May 2, 2024 | 207.60M | 5.27% |
May 1, 2024 | 197.20M | -2.42% |
Apr 30, 2024 | 202.10M | -0.30% |
Apr 29, 2024 | 202.70M | 5.74% |
Apr 26, 2024 | 191.70M | 9.42% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Lineage Cell Therapeutics | 188.82M |
INmune Bio | 186.94M |
Puma Biotechnology | 185.72M |
Fennec Pharmaceuticals | 185.24M |
Cellectis | 183.67M |
Cardiol Therapeutics | 180.78M |
Capricor Therapeutics | 180.69M |
Abeona Therapeutics | 180.39M |